Note: Descriptions are shown in the official language in which they were submitted.
CA 02489732 2004-12-09
FLEXIBLE INJECTION PORT
10
Field of the Invention
This invention relates generally to the field of medicine, and more
specifically to
medical devices that are surgically implanted in a patient, and is
particularly relevant to
irnplantable injection or infusion ports such as used for chemotherapy and
adjustable
gastric band procedures.
Background
Surgeons routinely implant subcutaneous injection ports in patients requiring
long
term, periodic fluid injections such as for chemotherapy and gastric band
adjushnents. The
injection port connects to a flexible tube catheter to transport the fluid to
the affected area
(subclavian vein, etc.) or the gastric band. Current injection ports comprise
a rigid metal or
plastic housing, which is about 25mm in diameter and l5mm tall. A thick,
silicone septum
captured within the rigid housing covers an inner chamber that fluidly
communicates with
the catheter. The surgeon uses a hypodermic needle to inject fluid into the
chamber through
the silicone septum.
Typically the surgeon fastens the injection port with suture to fascia and
beneath the fat
and skin layers, primarily to prevent the port from flipping over, but also to
prevent the
injection port from migrating in the body. Since the septum is accessible from
only one side
of the injection port, flipping over requires interventional surgery to right
the port for
subsequent injections.
For some patients, the surgeon may place the injection port in the lower
abdomen, thus
burying the port beneath a fat layer that may be several centimeters thick.
Usually a surgeon
can locate the port with palpation alone. However, if there is a very thick,
intervening fat
layer, such as on extremely obese, gastric band patients, the surgeon must
also use
fluoroscopy, ultrasound, or other means to locate the port. Furthermore, the
surgeon must
inject the needle in a direction approximately perpendicular to the injection
port, and hit the
target area of the septum, which is only about 12-1 Smm in diameter. For some
patients, the
1
CA 02489732 2004-12-09
surgeon may place the injection port on the sternum or upper right chest, just
beneath the
skin layers. Although easy to locate with palpation, some patients regard the
protruding port
as uncomfortable or cosmetically objectionable.
What is needed, therefore, is a subcutaneously implantable injection port that
is made of
relatively soft and flexible materials, and ideally, that looks and feels more
(than current
injection ports) like a large, natural blood vessel. What is also needed is a
subcutaneously
implantable injection port that is penetrable with a hypodemuc needle,
independent of the
orientation of the injection port in bodily tissue, and that is self sealing
when the needle is
removed. What is finther needed is a subcutaneously implantable injection port
that a
surgeon may position in the body more quickly and with less dissection than is
required for
conventional injection ports.
Summary of the Invention
An injection port for subcutaneous placement within a body. The injection port
includes an elongated flexible substantially non-rigid body having first and
second ends
and a wall therebetween. The wall is made from one or more materials such that
it will
self seal after being punctured by a needle. The body of the device further
includs and a
fluid reservoir surrounded by the wall. Lastly, the injection port includes a
flexible
elongated tubular catheter attached to the body which is in fluid
communication with the
reservoir.
Brief Description of the Drawings
We present the specific, novel features of this invention in the appended
claims.
The reader may best understand, however, the organization and methods of
operation of
this invention by referring to the detailed description and the following
drawings:
FIG. 1 is an isometric view of an injection port of the prior art;
FIG. 2 is a cross sectional view of the injection port of the prior art shown
in FIG. 1;
2
CA 02489732 2004-12-09
FIG. 3 is an isometric view of a first embodiment of a flexible injection port
30;
FIG. 4 is a sectional view of flexible injection port 30 shown in FIG. 3;
FIG. S is an enlarged, longitudinal sectional view of flexible injection port
30 penetrated
by a hypodermic needle 100;
FIG. 6 is a cross sectional view of a second embodiment of a flexible
injection port 50;
FIG. 7 is a cross sectional view of a third embodiment of a flexible injection
port 60;
FIG. 8 is an isometric view of a fourth embodiment of a flexible injection
port 80;
FIG. 9 is a cross sectional view of flexible injection port 80;
FIG. 10 shows injection port 30 subcutaneously implanted near a fascia layer
124 in a
patient;
FIG. 11 shows injection port 30 subcutaneously implanted near a skin layer 120
in a
patient; and
FIG. 12 shows injection port 30 subcutaneously implanted in a fat layer 122 in
a patient.
Detailed Description of the Invention
Referring now to the drawings, FIGS. 1 and 2 show an injection port 10 of the
prior art.
Injection port 10 generally has a truncated, conical configuration, and
comprises a body
portion 12, a housing 14, a seal element 16, and a catheter element 18. The
body portion 12
is made of a flexible, rubberized material with a cavity 20 formed inside. A
catheter support
22 integrally forms in body portion 12. Housing 14 is made of a corrosion
resistant metal,
3
CA 02489732 2004-12-09
and has a reduced, upwardly facing entry passage 24. Seal element 16 is made
of a
rubberized material, which is easily penetrable by a hypodermic needle or the
like, and
provides a penetrable seal for passage 24. Housing 14 and seal element 16
define an open
cavity 20 in injection port 10 for receiving and containing a fluid. Catheter
element 18
extends through catheter support 22 of body portion 12 and through housing 14
so that
catheter element 18 extends into cavity 20 for providing communication between
cavity 20
and the exterior of injection port 10 for dispensing fluid from the cavity 20
into the body of
a patient.
A surgeon implants injection port 10 subcutaneously in a patient. To introduce
a fluid
such as a medication or a saline solution, the surgeon inserts a hypodermic
needle or the like
into the patient so that the tip of the needle passes through seal element 16
and into cavity
20. Due to the relatively small size of passage 24, each time the surgeon
introduces a fluid
into the patient, the surgeon must insert the needle through seal element 16
and the same
localized area of the skin and tissue of the patient. Accordingly, seal
element 16 may
I S become significantly damaged and eventually develop a leak. Also, the
localized skin area
and underlying tissue may not heal in the desired manner. Further, because
housing 14 is
made of metal, it can cause barbing of the needle tip, causing increased
trauma to the patient
upon withdrawal of the needle. Still further, because of the truncated conical
configuration
of injection port 10 and the metallic construction of housing 14, injection
port 10 can cause
substantial discomfort to a patient, particularly if the area of the patient
adjacent the injection
port is accidentally bumped or bruised. In addition, because of the truncated
conical
configuration of injection port 10, it can cause a relatively unattractive
mound on the body
of a patient. Still further, since fluid can only be introduced in cavity 20
through passage 24,
a surgeon must insert a needle into injection port 10 in substantially
perpendicular relation to
the skin so that often the adjacent area of tissue or skin of the patient
cannot effectively
support the needle.
When using injection port 10 of the prior art in a laparoscopic procedure such
as
implantation of a gastric band, it is necessary for the surgeon to assemble
injection port 10 to
catheter element 18 during the laparoscopic procedure. This is because
injection port 10 is
too large to pass through a standard size (l2mm diameter) laparoscopic port,
which is used
for access to the stomach inside the abdominal cavity. The surgeon must
introduce the
4
CA 02489732 2004-12-09
gastric band and the catheter into the abdominal cavity without the injection
port attached to
the free end of the catheter. Once the surgeon has secured the gastric band
around the
stomach, the surgeon externalizes the free end of the catheter through the
abdominal muscle
and fascia layers, subcutaneous fat layer, and the skin to assemble the
injection port to the
free end of the catheter. Then the surgeon implants the injection port
subcutaneously at the
desired location on the patient's abdomen or chest. The surgeon must take
extra time to
assemble the injection port to the catheter. Also, the surgeon must skillfully
connect the
injection port to the catheter during less than ideal conditions.
Consequently, there is the
potential complication of an undiscovered leak developing at the connection of
the catheter
to the port.
FIG. 3 is an isometric view of a first embodiment of the present invention
showing a
flexible injection port or body 30, that generally comprises a first end 34, a
second end 36,
and a cylindrical injection portion 32 extending there between. A surgeon may
use a
hypodermic needle or the like to penetrate injection portion 32 and introduce
a fluid such as
a medication or saline solution into flexible injection port 30. Injection
portion 32 self seals
when the surgeon removes the hypodermic needle. Injection portion 32 may have
a length,
but is not limited to, approximately 5 - 20 cm. Injection portion 32 may have
a diameter,
but is not limited to, approximately 5 - 12 mm. A catheter 42 attaches to
first end 34 and
distributes fluid injected into flexible injection port 30 to another portion
of the patient's
body. Catheter 42 is made from a silicone rubber or other biocompatible
polymer such as
known in the art for application to conventional injection ports, such as
shown in FIGS 1 and
2. A tether 38 having an eye loop 40 extends from second end 36. A surgeon may
use a
conventional surgical grasping instrument to gasp tether 38, or a surgical
suture tied to eye
loop 40, or a combination of both grasper and suture, to facilitate placement
of flexible
injection port 30 in the body.
Although flexible injection port 30 is shown in FIG. 3 to be essentially
straight, it is
possible to construct it with a curved or non-straight shape in order to
facilitate placement in
the body, or to conform to the body anatomy at the implant location. Since
flexible injection
5
CA 02489732 2004-12-09
port 30 is made of relatively soft arid flexible materials, the surgeon may
temporarily
straighten it, for example, when introducing it into the body through a
laparoscopic port.
FIG. 4 is a cross sectional view of flexible injection port 30, taken at line
4-4 of injection
portion 32 as shown in FIG. 3. At this location and anywhere along the length
of injection
portion 32, flexible injection port 30 includes an outer tube 44 may exerts a
radial,
compressive force on an inner tube 46. Flexible injection port 30 includes a
fluid reservoir
48 that extends the entire length of injection portion 32 and fluidly
communicates with
catheter 42. The total wall thickness is approximately in the range of 2 -
4mm.
FIG. 5 is a longitudinal sectional view of flexible injection port 30, showing
a
hypodermic needle 100 penetrating through injection portion 32 so that distal
tip 102 of
hypodermic needle 100 is inside of fluid reservoir 48. First end 34, second
end 36, tether
38, eye loop 40, and inner tube 46 are integrally molded from an elastomer
such as, for
example, silicone rubber, latex rubber, or polyurethane rubber. The molded
elastomer may
have a durometer approximately in the range of 40-60, but is not limited to
that range.
Catheter 42 may be bonded inside of first end 34 using any one of a number of
bonding
agents and techniques well known in the art, in order to fluidly communicate
with reservoir
48. Outer tube 44 may be made of a PTFE shrink-wrap material, or a similar,
biocompatible
shrink-wrap. During the manufacturing process, outer tube 44 may be loosely
assembled in
the pre-shrunken configuration over inner tube 46. Then the application of
heat causes outer
tube 44 to conform very tightly around inner tube 46. Outer tube 44 therefore
applies a
significant compressive force on the softer, inner tube 46 to enhance the
ability of inner tube
46 to close the puncture created by hypodermic needle 100.
FIG. 6 is a cross sectional view of a second embodiment of the present
invention
showing a flexible injection port 50, which is externally similar to the first
embodiment
shown in FIG. 3. Flexible injection port 50 includes an outer tube 52, an
inner tube 54, and
an inner lining 56. Outer tube 52 and inner tube 54 are the same as outer tube
44 and inner
tube 46, respectively, of the first embodiment in FIG. 4. Inner lining 56 may
be an extruded
6
CA 02489732 2004-12-09
plastic, thin wall tube, such as polyethylene or PTFE, tightly assembled
inside of inner. tube
54 to provide internal support to inner tube 54. By supporting inner tube 54
in this way, a
greater compressive force may be applied by outer tube 52 onto inner tube 54,
to further
enhance the self sealing capability. The material of inner lining 56 may be
sel~ted to have
a higher needle penetration resistance than inner tube 54. This difference in
penetration
resistance provides the surgeon with tactile feedback that the needle tip has
penetrated into
fluid reservoir 58. Inner lining 56 may also be constructed of a metallic mesh
and be similar
in many respects to a vascular stent. Again, the total wall thickness is
approximately in the
range of 2 - 4 mm.
FIG. 7 is a cross sectional view of a third embodiment of the present
invention showing a
flexible injection port 60, which also is externally similar to the first
embodiment shown in
FIG. 3. Flexible injection port 60 comprises a plurality of layers 61, which
for this third
embodiment includes a first layer 62, a second layer 64, a third layer 66, a
fourth layer 68,
and a fifth layer 70, which surrounds a fluid reservoir 72. . Once penetrated
by a needle
that is inserted at an acute angle, the punctures created through the layers
are not aligned to
allow leakage once the needle is removed. Each of layers 61 may be made of the
same or a
different material than any of the other of layers 61, or may have the same or
a different
thickness than any of the other of layers 61. Each of layers 61 may have a
specific property
or functional contribution. For example, first layer 62 may be made of a
material that is
permeable to tissue fluids in order to slowly release a medication contained
in second layer
64. Fifth layer 70 may be made of silicone rubber having a durometer in the
range of 20 -
30. Fourth layer 68 may be made of a heat shrinkable PTFE material, which
applies a
radially compressive force on fifth layer 70 to enhance self sealing. Third
layer 66 may be
made of a material such as a metallic foil that acts as a diffusion barrier to
prevent the loss of
fluid from fluid reservoir ?2. Fourth layer 66 may be made of a high durometer
silicone
rubber. Many other materials are possible, in a multiplicity of combinations,
so that
injection port 60 may have characteristics especially suited for its
particular application.
Diffusion of body fluids into and out of the soft port wall may also be
reduced by any one of
various material treatment techniques, including, for example, vapor
deposition of titanium
or another metal on a surface of the soft port, and coating with Paralene
polymer. Other
7
CA 02489732 2004-12-09
coatings are also known in the art for micro bacterial protection. Again, the
total wall
thickness is in the range of 2 - 4 mm.
FIG. 8 is a fourth embodiment of the present invention, a flexible injection
port 80,
comprising a first end 84 that attaches to a catheter 92, a second end 86 and
an inj~tion
portion 82. Flexible injection port 80 further comprises a webbing 88 attached
to and
covering at least injection portion 82, and made of a thin, flexible,
implantable material such
as a polyester or polypropylene mesh, expanded PTFE, or the like. Webbing 88
provides
broad margins for stapling or suturing to an underlying tissue such as fascia,
as well as a
large area for tissue in-growth, to enhance long-term stability and to
substantially prevent
migration of flexible injection port 80. FIG. 9 is a cross sectional view of
flexible injection
port 80, taken at line 9-9 of FIG. 8. Flexible injection port 80 comprises an
outer tube 94
made of a heat shrinkable, PTFE material, and an inner tube 96 made of a
silicone rubber
having a durometer of approximately 20-40. Webbing 88 includes a pair of
webbing layers,
91 and 93, that may be bonded thermally or chemically tightly over at least
injection portion
82 in the mid-plane of flexible injection port 80.
A surgeon may implant the present invention, as described for the preceding
embodiments and equivalents, in a number of locations in a patient's body.
FIGS 10, 11,
and 12 show examples of flexible injection port 30 subcutaneously implanted in
the
abdomen of a patient, although it is possible to implant flexible injection
port 30 beneath the
skin in other portions of the body.
FIG. 10 depicts a first example of flexible injection port 30 subcutaneously
implanted in
a patient's body. Flexible injection port 30 lies adjacent to a fascia layer
124 covering an
abdominal wall 126. Catheter 42 passes from the abdominal cavity 128 through
an
abdominal opening 132, which the surgeon used together with a first incision
130 for
laparoscopic access earlier in the surgical procedure. The surgeon optionally
may make a
second incision 134 offset from first incision 130, and use conventional,
surgical grasping
and retracting instruments to pull flexible injection port 30 beneath a fat
layer 122 and
adjacent to fascia layer 124. However, the surgeon may determine that it is
not necessary to
make a second incision 134, and instead use first incision 130 to push
flexible injection port
30 into position. In either situation, the surgeon dissects as little tissue
as practical in order
8
CA 02489732 2004-12-09
to save surgery time and to minimize the size of enclosed cavities that may
collect tissue
fluids and become sites for infection. The surgeon optionally may anchor
flexible injection
port 30 to fascia layer 124 with a stay suture 102. Once the surgeon has
placed flexible
injection port 30 in the desired location, the surgeon closes first incision
130 and second
S incision 134 using conventional sutures or staples.
FIG. 11 shows a second example of flexible injection port 30 subcutaneously
implanted
in a patient's body. Flexible injection port 30 lies immediately beneath skin
layer 120 and
above fat layer 122. Catheter 42 passes through first incision 130 and
abdominal opening
132 (the original laparoscopic port site) into abdominal cavity 128. The
surgeon may use
forger or instrument dissection through first incision 130 to create a space
under skin layer
120 for flexible injection port 30. The surgeon closes first incision 130
using conventional
sutures or staples. Normally it would not be necessary to close abdominal
opening 132
through fascia layer 124 and abdominal wall 126, but the surgeon may do so in
order to
promote healing and to prevent slippage of catheter 42 through abdominal
opening 132.
The surgeon may prefer placement of flexible injection port 30 just beneath
skin layer 120
for severely obese patients in which fat layer 122 is over 5-10 cm thick, so
that the surgeon
may easily use palpation to locate flexible injection port 30 for later
injections of fluid.
Also, conventional intravenous (IV) needles and techniques may be used for
injecting the
fluid into flexible injection port 30, which is situated beneath the skin much
like a natural
blood vessel. This may allow nurses and other clinicians who are trained in
administering
IV's to assist the surgeon with fluid injections. Furthermore, if the
clinician uses a
conventional IV needle, the "flashback" of fluid into the IV needle syringe
tip provides the
clinician with visual feedback that the tip of the needle is properly
penetrated into the
reservoir of flexible injection port 30. In fact, addition of a colorant to
the fluid injected
further enhances this visual feedback. Non-toxic colorants that may be added
to the saline
solution or medication are well known in the art.
FIG. 12 shows a third example of flexible injection port 30 subcutaneously
implanted in
a patient's body. For this example, the surgeon does minimal or no dissection
of tissue at
the laparoscopic port site. Catheter 42 passes from the abdominal cavity 128
through fascia
layer 124 and abdominal wall 126. The surgeon positions flexible injection
port 30
vertically in fat layer 122 and beneath skin layer 120. Optionally, the
surgeon may suture
9
CA 02489732 2004-12-09
abdominal opening 132 to prevent slippage of flexible injection port 30 into
abdominal
cavity 128. The surgeon also may use a surgical scissors to trim off tether 38
from flexible
injection port 30, just prior to closing first incision 130 with conventional
sutures or staples.
The present invention, a flexible injection port, as described in the
preceding
embodiments and their equivalents, has numerous advantages over the prior art
injection
ports. The flexible injection port may not require attachment to fascia, thus
reducing the
duration of the surgical procedure. The flexible injection port may require a
smaller incision
size and less tissue dissection for implantation, so that the patient has less
pain, less scarring,
a faster recovery, and less possibility of infection. Due to the integral
construction of the
flexible injection port and the catheter, the step of connecting the catheter
to the injection
port during the surgical procedure is not necessary, thus potentially reducing
the number of
surgical complications due to fluid leakage at the connection. Because the
flexible injection
port may be implanted in the fat layer near the skin surface, the surgeon or a
trained
clinician may use palpation to locate the injection port, and standard IV
techniques to
administer fluid, yet the implant is still cosmetically acceptable to the
patient. In addition,
shorter injection needles may be used to reduce patient anxiety during fluid
administration.
The flexible injection port may have no metallic parts, resulting in a
flexible and lightweight
implant for greater patient comfort and compatibility with magnetic resonance
and
fluoroscopic x-ray imaging. Finally, the injection portion of the flexible
injection port is
accessible with a hypodermic needle for most of the possible orientations of
the flexible
injection port within the subcutaneous fat layer of the patient.
While preferred embodiments of the present invention have been shown and
described herein, it will be obvious to those skilled in the art that such
embodiments are
provided by way of example only. Numerous variations, changes, and
substitutions will
now occur to those skilled in the art without departing from the invention.
For example,
the injection port may me coated with an anit-microbial coating such as
triclosan. For
example, as would be apparent to those skilled in the art, the disclosures
herein have
equal application in robotic-assisted surgery. In addition, it should be
understood that
every structure described above has a function and such structure can be
referred to as a
means for performing that function. Accordingly, it is intended that the
invention be
limited only by the spirit and scope of the appended claims.
